Research Article
Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma
Table 1
The characteristics of the NSCLC patients.
| | Characteristics | No |
| | Total | 264 (100%) | | Age | | | ≤60 | 149 (56.44%) | | 60 | 115 (43.56%) | | Gender | | | Man | 186 (70.46%) | | Woman | 78 (29.54%) | | Smoke | | | Yes | 156 (59.09%) | | No | 108 (40.91%) | | Smoke index | | | ≤400 | 46 (29.49%) | | 400 | 110 (70.51%) | | Pathology type | | | S | 130 (49.24%) | | A | 134 (50.76%) | | Tumor site | | | Right | 115 (43.56%) | | Left | 149 (56.44%) | | Differentiation | | | Well + moderate | 161 (60.98%) | | Poor | 103 (39.02%) | | Tumor size | | | cm | 130 (49.2%) | | cm | 134 (50.8%) | | Lymph node stage | | | N0 | 124 (47.0%) | | N1, 2, 3 | 140 (53.0%) | | Distant metastasis | | | M0 | 189 (71.6%) | | M1 | 75 (28.4%) | | Clinical stage | | | I | 74 (28.03%) | | II | 39 (14.77%) | | III | 76 (28.79%) | | IV | 75 (28.41%) |
|
|
S: squamous cell carcinoma.
A: adenocarcinoma.
Define as the significant difference.
|
